Why the ResApp Health Ltd (ASX:RAP) share price has been smashed today

The ResApp Health Ltd (ASX:RAP) share price has been smashed today. It fell 59% in early trade following a disappointing update…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The ResApp Health Ltd (ASX: RAP) share price has been one of the worst performers on the market on Tuesday following the release of its SMARTCOUGH-C-2 study results.

At one stage the digital healthcare company's shares were down as much as 59% to 9 cents. They have since rebounded slightly but are still down a whopping 50% to 10 cents.

Why are ResApp's shares crashing lower?

ResApp has been busy running a study for the diagnosis of childhood respiratory disease using cough sounds and its ResAppDx smartphone application.

Although management has labelled the preliminary results for the double-blind, prospective study as "positive", as you might have guessed from the share price reaction, investors were expecting far better.

Management revealed that the study achieved a positive percent agreement (PPA) between 73% and 78% and a negative percent agreement (NPA) between 71% and 86%.

This is compared to a clinical diagnosis for lower respiratory tract disease, asthma/reactive airway disease (for children over 2 years of age) and primary upper respiratory tract disease.

These figures are really nothing to get excited about in my opinion and I can't say I'm surprised to see its shares crash lower today. I was expecting something in the mid to high 80s.

Nevertheless, management intends to pursue FDA submissions for lower respiratory tract disease, asthma/reactive airways disease, and primary upper respiratory tract disease diseases in parallel to CE and TGA submissions for six diseases being prepared following the recent Australian study results.

Should you buy the dip?

While the SMARTCOUGH-C-2 study was by no means as disastrous as the original SMARTCOUGH study, it is starting to look as though the company has wasted a lot of time and resources on this one.

Overall, I would suggest that investors stay clear of the company and focus on opportunities elsewhere.

Small cap healthcare shares such as Nanosonics Ltd (ASX: NAN) and Volpara Health Technologies Ltd (ASX: VHT) could be great alternatives.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Nanosonics Limited and VOLPARA FPO NZ. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Fallers

A young man clasps his hand to his head with his eyes closed and a pained expression on his face as he clasps a laptop computer in front of him, seemingly learning of bad news or a poor investment.
Share Fallers

Why Burgundy Diamond Mines, Clarity Pharmaceuticals, EML, and Zip are sinking today

These ASX shares are ending the week in the red. But why?

Read more »

A worried man holds his head and look at his computer.
Share Fallers

Why 29Metals, Brainchip, Platinum, and Premier Investments shares are falling today

These ASX shares are having a tough time on hump day.

Read more »

Man with his head in his head because of falling share price.
Share Fallers

Why 29Metals, Atlas Arteria, IDP Education, and Mineral Resources shares are falling

These ASX shares are having a tough time on Tuesday. But why?

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Fallers

Why ALS, EOS, NRW, and Patriot Battery Metals are dropping today

These ASX shares are starting the week in the red.

Read more »

A man looking at his laptop and thinking.
Technology Shares

Why are these ASX tech shares getting smashed today?

Owners of these two stocks are missing out today.

Read more »

a man weraing a suit sits nervously at his laptop computer biting into his clenched hand with nerves, and perhaps fear.
Share Fallers

Why AGL, Brickworks, IGO, and New Hope shares are dropping today

These ASX shares are having a poor session. But why?

Read more »

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
Share Fallers

Why Amcor, Arafura, Brainchip, and South32 shares are tumbling today

These ASX shares are having a tough time on hump day. But why?

Read more »

A young woman holds an open book over her head with a round mouthed expression as if to say oops as she looks at her computer screen in a home office setting with a plant on the desk and shelves of books in the background.
Share Fallers

Why Aussie Broadband, Liontown, Metals Acquisition, and Seek shares are falling

These ASX shares are having a poor session. But why?

Read more »